Randomized Phase II Trial of the Cyclin-Dependent Kinase Inhibitor Dinaciclib (MK-7965) Versus Capecitabine in Patients With Advanced Breast Cancer - Concepedia

Concepedia

Publication | Closed Access

Randomized Phase II Trial of the Cyclin-Dependent Kinase Inhibitor Dinaciclib (MK-7965) Versus Capecitabine in Patients With Advanced Breast Cancer

151

Citations

22

References

2013

Year

Monica Mita, Anil A. Joy, Alain C. Mita, Kamalesh K. Sankhala, Ying-Ming Jou, Da Zhang, Paul Statkevich, Yali Zhu, Siu-Long Yao, Karen Small,

Clinical Breast Cancer

Advanced Breast CancerBreast OncologyOncologyPhase Ii TrialMedicineBreast CancerPharmacotherapyAnti-cancer AgentCancer TreatmentVersus CapecitabinePharmacology

References

	Year	Citations

Page 1

Page 1